ALTERVOL: Hemodynamic Indices Predictive of a Beneficial Response to Fluid Expansion in Case of Hemodynamic Failure After Cardiac Surgery With Altered Preoperative Ejection Fraction (LVEF≤45%)

Sponsor
Rennes University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01673230
Collaborator
(none)
50
1
1
39
1.3

Study Details

Study Description

Brief Summary

Low Cardiac Output Syndrome occurs frequently after cardiac surgery, especially when pre-operative LVEF is altered (LVEF≤45%). The correction of hemodynamic failure requires adapted treatments: fluid expansion and/or inotropic or vasoactive drugs. Predictive indices of a response to fluid challenge may allow an earlier hemodynamic optimization, which has not been showed until now when LVEF is altered.

Condition or Disease Intervention/Treatment Phase
  • Procedure: cardiac surgery for ventricular dysfunction
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Hemodynamic Indices Predictive of a Beneficial Response to Fluid Expansion in Case of Hemodynamic Failure After Cardiac Surgery With Altered Preoperative Ejection Fraction (LVEF≤45%): Sensibility and Specificity of Respiratory Variations of Pulse Pressure (∆PP), Photoplethysmography (∆POP), Perfusion Index (PVI), Before and After Fluid Expansion.
Study Start Date :
Sep 1, 2012
Actual Primary Completion Date :
Dec 1, 2015
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Other: Ventricular dysfunction

cardiac surgery for ventricular dysfunction

Procedure: cardiac surgery for ventricular dysfunction
For each included patient during the immediate post operative period, hemodynamic variables will be recorded (continuous arterial pressure, ECG, photoplethysmographic curve, CVP, wedge pressure, respiratory pressure), at rest (proclive 45°), during fluid expansion (physiological saline).

Outcome Measures

Primary Outcome Measures

  1. Measure of ∆PP, ∆POP, PVI and Cardiac index (CI) [2 hours]

    To assess the sensibility and specificity of ∆PP, ∆POP, PVI, after fluid expansion in case of hemodynamic failure in the immediate post-operative period after cardiac surgery, when pre-operative LVEF is altered.

Secondary Outcome Measures

  1. Measure of Systolic, diastolic and mean arterial pressure (SAP, DAP, MAP), Central venous pressure (CVP) and wedge pressure. [2 hours]

    Secondary objectives : Early optimization of hemodynamics after cardiac surgery, To determine optimal threshold for ∆PP, ∆POP and PVI, To compare dynamic (∆PP, ∆POP and PVI) with static (central venous pressure: CVP, wedge pressure) indices

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients >18 years old in the immediate post-operative period after cardiac surgery

  • ASA 1 - 3

  • Pre-operative LVEF≤45%

  • Sedated with Ramsay score: 6

  • Mechanically ventilated with tidal volume at 8ml/kg, PEEP at 0mmHg, I/Eat 0,5

  • With hemodynamic failure: SAP≤90mmHg and/or inotropic or vasoactive drug started in the operating room and/or clinical sign of shock and/or CI ≤2,3l/min/m2

  • Affiliation to Health Insurance

  • Consent form signed

Exclusion Criteria:
  • Cardiac arrhythmia: frequent atrial or ventricular extra systoles, atrial fibrillation

  • Intracardiac shunt

  • Weight less than 50 kg

  • History of central nervous system illness

  • Pulmonary oedema (clinical and/or radiological and/or wedge pressure>18mmHg)

  • Right ventricular failure suspected (CVP> wedge pressure) or diagnosed (trans thoracic and/or transesophageal echocardiography)

  • Acute kidney injury with oligoanuria

  • Severe post operative bleeding (chest tubes volume of >200ml/h for 3 hours or more)

  • Severe hypoxia (PaO2/FIO2< 100)

  • Administrative control (patient under guardianship or curatorship)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rennes University Hospital Rennes Brittany France 35033

Sponsors and Collaborators

  • Rennes University Hospital

Investigators

  • Principal Investigator: patrick guinet, Rennes University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rennes University Hospital
ClinicalTrials.gov Identifier:
NCT01673230
Other Study ID Numbers:
  • 2012-A00364-39
  • LOC/12-01
First Posted:
Aug 27, 2012
Last Update Posted:
Dec 27, 2019
Last Verified:
Mar 1, 2016
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 27, 2019